| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1515566A Substituted chromene derivative for curing inflammation |
| 07/28/2004 | CN1515555A Method for preparing 7-bromine quinolone carboxylic acid derivative or its salt |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515547A Naphthol derivative |
| 07/28/2004 | CN1515259A 4-aminosubstituted-2-substituted-1,2,3,4-tetrahydroquinoline used as CETP inhibitor |
| 07/28/2004 | CN1159312C Novel poyrimidine derivatives and process for preparation thereof |
| 07/28/2004 | CN1159311C Dihydropyrimidines |
| 07/28/2004 | CN1159286C Preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 07/27/2004 | US6767914 Fluorinated heterocyclic compounds and methods of synthesis |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004037773A8 Phenethanolamine derivative for the treatment of respiratory diseases |
| 07/22/2004 | US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst |
| 07/22/2004 | US20040142980 Viricides; hepatitis virus infections |
| 07/22/2004 | US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/22/2004 | US20040142878 N-cycloalkylglycines as HIV protease inhibitors |
| 07/22/2004 | US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process. |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1251123B1 Process for preparing quinolylacrylonitrile and intermediates therefor |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | CN1514824A Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 07/21/2004 | CN1513939A Organic electroluminous material and its preparation method and application |
| 07/21/2004 | CN1513841A Quinolinenone kind derivative and its accetable salt, its preparation method, application in preparation of alipyrazole and preparation of alipyrazole |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 07/21/2004 | CN1158265C Quinoline ketone derivant and antianaphylaction using same as active substance |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/21/2004 | CN1158259C Potassium channel openers |
| 07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 07/20/2004 | CA2079703C Novel 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines |
| 07/15/2004 | WO2004058726A2 CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST β-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/15/2004 | WO2004058260A1 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives |
| 07/15/2004 | WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 07/15/2004 | WO2004058164A2 Asthma and allergic inflammation modulators |
| 07/15/2004 | WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 07/15/2004 | WO2004035736A3 Halogenated selective androgen receptor modulators and methods of use thereof |
| 07/15/2004 | WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138468 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/15/2004 | US20040138467 Controlling electroconductors and structures for computers or semiconductors |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138456 Environment-sensitive luminescent dimine-platinum binuclear complexes |
| 07/15/2004 | US20040138288 Anticancer compounds |
| 07/15/2004 | US20040138272 Central nervous system disorders; anticancer agents; antiproliferative agents |
| 07/15/2004 | US20040138257 Chemical derivatives and their application as antitelomerase agent |
| 07/15/2004 | US20040138229 Platelet adenosine diphosphate receptor antagonists |
| 07/15/2004 | US20040138228 Novel compounds with analgesic effect |
| 07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
| 07/15/2004 | US20040138211 Antidiabetic agents; hypotensive agents; insulin resistance; antilipemic agents; cardiovascular disorders ; anticholesterol agents |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040138195 Activation using enzyme or ionizing radiation |
| 07/15/2004 | US20040138183 Bactericides; anticarcinogenic agents; modulation of gene expression; therapy for antibiotic resistant bacteria |
| 07/15/2004 | DE19950404B4 Mittel und Verfahren zur Färbung von Haaren sowie ein Mehrkomponenten-Kit zum Färben und späteren Entfärben von Haaren Means and method for coloring hair and a multi-component kit for dyeing and subsequent decolouring of hair |
| 07/15/2004 | CA2511496A1 Cardiotonic compounds with inhibitory activity against .beta.-adrenergic receptors and phosphodiesterase |
| 07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435953A1 Antivesicant compounds and methods of making and using thereof |
| 07/14/2004 | EP1435946A2 Linked biaryl compounds |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435782A1 Treatment for cystic fibrosis |
| 07/14/2004 | EP1282595B1 Novel phenyl-propargylether derivatives |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
| 07/14/2004 | CN1512984A Process for preparation of quinoline carboldehyde |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1157394C Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds |
| 07/14/2004 | CN1157388C Piperazine dithioformates compounds, their preparation method and application in cancer-resisting medicine |
| 07/14/2004 | CN1157378C Qunoline derivatives |
| 07/13/2004 | CA2386775C Drugs for the treatment of malignant tumours |
| 07/13/2004 | CA2272690C Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives |
| 07/13/2004 | CA2255333C Quinolinone derivative, method for preparing the same, and anti-allergic agent |
| 07/09/2004 | WO2004063162A1 Process for preparing aripiprazole |
| 07/09/2004 | CA2676216A1 Aripiprazole |
| 07/08/2004 | WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments |
| 07/08/2004 | WO2004056781A1 Processes for preparing quinolonecarboxylate derivatives |
| 07/08/2004 | WO2004056780A2 Tetrahydroquinoline derivatives |
| 07/08/2004 | WO2004056779A2 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 07/08/2004 | WO2004056755A2 Compounds for the inhibition of non-proteolytic enzymes |
| 07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056735A1 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties |
| 07/08/2004 | WO2004056322A2 Antibiotics containing borinic acid complexes and methods of use |
| 07/08/2004 | WO2004041210A3 Antibacterial agents |
| 07/08/2004 | WO2004012663A3 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | US20040132993 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 07/08/2004 | US20040132778 Method for treating retroviral infections |
| 07/08/2004 | US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 07/08/2004 | US20040132770 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen |
| 07/08/2004 | US20040132769 Certain phenylacetic acids and derivatives |